Tag: Immutep
Immutep: Reveals encouraging interim results from phase two TACTI-002 study
Immutep (IMM) has released further interim data from its Phase II TACTI-002 Study in patients with lung, head, and neck cancers
The study...
Immutep: Partners with LabCorp
Immutep (IMM) has entered a license and collaboration agreement with Laboratory Corporation of American Holdings (LabCorp)
The companies will also collaborate to develop...
Immutep: Sees improved results from two cancer trial
Cancer treatment company Immutep (IMM) has seen improving results from its cancer trials, INSIGHT-004 and TACTI-002
For the INSIGHT-004 trial, the company is...